Fingerprint
Dive into the research topics of 'Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically